行情

CRMD

CRMD

CORMEDIX
NASDAQ
2.850
+0.020
+0.71%
交易中 10:44 10/03 EDT
开盘
2.850
昨收
2.830
最高
2.900
最低
2.770
成交量
8,297
成交额
1.48万
52周最高
8.03
52周最低
2.645
市值
1.17亿
市盈率(TTM)
-3.5430
分时
5日
1月
3月
1年
5年
暂无数据
CRMD 简况
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its lead product candidate, DefenCath, for commercialization in the United States. The DefenCath/Neutrolin is an anti-infective solution, a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis and total parenteral nutrition. DefenCath product is available in Europe and other territories under the brand name Neutrolin.

微牛提供CorMedix Inc.(NASDAQ-CRMD)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CRMD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRMD股票基本功能。